Passive–active immunoprophylaxis for all infants born from HBeAG‐negative chronic HBV‐infected mothers: Is it a cost‐effective strategy?

[1]  C. Barbatis,et al.  Intrauterine-transplacental transmission of hepatitis B virus (HBV) from hepatitis B e antigen negative (precore mutant, G1896A) chronic HBV infected mothers to their infants. Preliminary results of a prospective study. , 2007, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[2]  S. Alavian,et al.  Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus in infants born to HBsAg positive mothers in comparison with vaccine alone. , 2006, Hepatology research : the official journal of the Japan Society of Hepatology.

[3]  S. Hadziyannis,et al.  Hepatitis B e Antigen-Negative Chronic Hepatitis B: Natural History and Treatment , 2006, Seminars in liver disease.

[4]  N. Fotos,et al.  HBeAg negative serological status and low viral replication levels characterize chronic hepatitis B virus-infected women at reproductive age in Greece: a one-year prospective single center study. , 2005, World journal of gastroenterology.

[5]  K. Pantazis,et al.  Relationship between serum b2-microglobulin levels and virological breakthrough in HBeAg-negative chronic hepatitis B patients, under long-term treatment schedules including lamivudine. , 2005, World journal of gastroenterology.

[6]  G. Norkrans,et al.  Hepatitis B Virus DNA during Pregnancy and Post Partum: Aspects on Vertical Transmission , 2003, Scandinavian journal of infectious diseases.

[7]  Hong Yang,et al.  Quantitative analysis of HBV DNA level and HBeAg titer in hepatitis B surface antigen positive mothers and their babies: HBeAg passage through the placenta and the rate of decay in babies , 2003, Journal of medical virology.

[8]  Mei-Hwei Chang,et al.  Role of hepatitis B immunoglobulin in infants born to hepatitis B e antigen-negative carrier mothers in Taiwan , 2003, The Pediatric infectious disease journal.

[9]  D. West,et al.  Field evaluation of the efficacy and immunogenicity of recombinant hepatitis B vaccine without HBIG in newborn Vietnamese infants , 2002, Journal of medical virology.

[10]  H. Trübel,et al.  Mutations in the basic core promotor and the precore region of hepatitis b virus and their selection in children with fulminant and chronic hepatitis B , 1999, Hepatology.